Targeting galectin-driven regulatory circuits in cancer and fibrosis
Galectins are a family of endogenous glycan-binding proteins that have crucial roles in a
broad range of physiological and pathological processes. As a group, these proteins use …
broad range of physiological and pathological processes. As a group, these proteins use …
Insights into the role of sialylation in cancer progression and metastasis
C Dobie, D Skropeta - British Journal of Cancer, 2021 - nature.com
Upregulation of sialyltransferases—the enzymes responsible for the addition of sialic acid to
growing glycoconjugate chains—and the resultant hypersialylation of up to 40–60% of …
growing glycoconjugate chains—and the resultant hypersialylation of up to 40–60% of …
Integrating artificial intelligence and nanotechnology for precision cancer medicine
Artificial intelligence (AI) and nanotechnology are two fields that are instrumental in realizing
the goal of precision medicine—tailoring the best treatment for each cancer patient. Recent …
the goal of precision medicine—tailoring the best treatment for each cancer patient. Recent …
Pathological implication of protein post-translational modifications in cancer
S Pan, R Chen - Molecular aspects of medicine, 2022 - Elsevier
Protein post-translational modifications (PTMs) profoundly influence protein functions and
play crucial roles in essentially all cell biological processes. The diverse realm of PTMs and …
play crucial roles in essentially all cell biological processes. The diverse realm of PTMs and …
Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology
Data-independent acquisition mass spectrometry (DIA-MS) is a next generation proteomic
methodology that generates permanent digital proteome maps offering highly reproducible …
methodology that generates permanent digital proteome maps offering highly reproducible …
Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks
Decades of research have disclosed a plethora of alterations in protein glycosylation that
decisively impact in all stages of disease and ultimately contribute to more aggressive cell …
decisively impact in all stages of disease and ultimately contribute to more aggressive cell …
Glycosylation markers in cancer
A Silsirivanit - Advances in clinical chemistry, 2019 - Elsevier
Alteration of glycosylation, a hallmark of cancer, results in the production of tumor-
associated glycans or glycoproteins. These molecules are subsequently secreted or …
associated glycans or glycoproteins. These molecules are subsequently secreted or …
Cancer biomarker discovery and translation: proteomics and beyond
VA Hristova, DW Chan - Expert review of proteomics, 2019 - Taylor & Francis
Introduction: Cancer is often diagnosed at late stages when the chance of cure is relatively
low and although research initiatives in oncology discover many potential cancer …
low and although research initiatives in oncology discover many potential cancer …
Recent advances in glycoproteomic analysis by mass spectrometry
S Suttapitugsakul, F Sun, R Wu - Analytical chemistry, 2019 - ACS Publications
Glycosylation is one of the most common protein modifications and is essential for cells. This
modification is exceptionally complex because glycans are highly diverse and can be …
modification is exceptionally complex because glycans are highly diverse and can be …
[HTML][HTML] Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges
M Pal, T Muinao, HPD Boruah, N Mahindroo - Biomedicine & …, 2022 - Elsevier
Solid cancers are one of the leading causes of cancer related deaths, characterized by rapid
growth of tumour, and local and distant metastases. Current advances on multimodality care …
growth of tumour, and local and distant metastases. Current advances on multimodality care …